February 21, 2022 – A research group the Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, has revealed for the first time that the thrombus generated by ulcerated plaque (UP) observed in the femoropopliteal artery (FPA) during angioscopy is the source of embolization of the popliteal artery.

February 21, 2022 – Acute coronary syndromes (such as heart attacks) and strokes are a leading cause of morbidity and mortality in the U.S. and Europe. About 80 percent of those events occur because a build-up of plaque in the arteries—or atherosclerotic plaque (AP)—ruptures.

February 21, 2022 – Nuwellis, Inc. has announced the company will evaluate the clinical outcomes and economic value of its Aquadex therapy in comparison to intravenous diuretics for the treatment of fluid overload in patients with worsening

February 21, 2022 – Researchers at Michigan Medicine have found a novel method of measuring growth in the body’s largest artery that may help clinicians to identify potentially fatal heart conditions earlier.

January 18, 2022 – Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has developed a new sternal closure device to improve patient recovery after open chest surgery. The patented orthopedic device, made of a high-performance polymer from Evonik, closes and holds the sternum securely together after surgery. 

February 18, 2022 – Daxor Corporation, the global leader in blood volume measurement technology, has announced new data demonstrating the importance and clinical utility of Daxor’s BVA-100 blood test in heart failure (HF) patients published in the

February 18, 2022 – Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of its COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System), as U.S. and Canadian hospitals continue to implement the life-saving aortic occlusion device during various surgical and emergency cases.

February 18, 2022 — GE Healthcare has announced that it has received approval from the European Medicines Agency (EMA) for additional imaging modalities for its stress agent Rapiscan (Regadenoson).

We are launching something new—a Clinical Case of the Month—and we want you to contribute! Do you have a clinical case you’d like to share with DAIC's audience? If so, please send high-resolution images and a brief written case study to [email protected]

Share your unique cases with your peers! The Clinical Case of the Month will be updated regularly, and featured both online and in the digital edition of DAIC.

February 17, 2022 — While cardiac imaging shows that COVID-19 vaccine–associated myocarditis has a similar pattern as that from other causes, the abnormalities are less severe and result in less functional impairment, suggests a study yesterday in Radiology.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now